Could a rheumatoid arthritis drug help stop scarring hair loss?
NCT ID NCT06240351
Summary
This small pilot study is testing whether baricitinib, a medication used for rheumatoid arthritis, is safe and effective for treating frontal fibrosing alopecia (FFA). FFA is a condition that causes permanent, scarring hair loss at the front of the scalp and eyebrows. The study will measure if the drug reduces inflammation, itching, pain, and slows the progression of hair loss in 15 adult women with active FFA.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRONTAL FIBROSING ALOPECIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
Conditions
Explore the condition pages connected to this study.